Intravenous-to-Subcutaneous Drug Repositioning Market By Product (Device Analysis and Drug Product Analysis), By Therapeutic Sector (Cardiology, Edema, Pulmonary Arterial Hypertension, Hematology, Blood Factors, and Oncology), By Technology (Drug Formulation, Injection Site Modification, and Device Innovation), Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018-2026

pa_user-types

Check Today's Best Price

$3500 Buy Now
Global Intravenous-To-Subcutaneous Drug Repositioning market is estimated to reach $XX Million by 2026; growing at a CAGR of XX% from 2019 to 2026.
  • Market Definition

    Drug repositioning (also known as drug repurposing or drug reprofiling) is the application of available drugs for treating conditions different from the original treatment purposes. Drug repositioning is supported by the point that common molecular pathways contribute to many diverse diseases. On the other hand, intravenous to subcutaneous drug repositioning is the technique of positioning therapies that involves infusion by medical professionals as subcutaneous (SC) injectable in prefilled devices that are safe and effective when self-administered by the patient.

    Global Intravenous-To-Subcutaneous Drug Repositioning market is estimated to reach $XX Million by 2026; growing at a CAGR of XX% from 2019 to 2026.

    Market Dynamics

    IV-to-SC drug repositioning offers many advantages over traditional drug discovery approaches which primarily drive the global market. Then again, it significantly reduces the cost and development time as compared to the traditional therapies, which also propels the market growth. However, lack of awareness regarding these therapies across developing regions may hamper the market from growing. Moreover, an increase in developing research labs and infrastructure for conducting drug repositioning clinical trials is expected to generate numerous growth opportunities for the market in the forthcoming years.

    Market Segmentation

    The global intravenous-to-subcutaneous drug repositioning market is classified based on technology, product type, and therapeutic sector. Based on technology, the market is sub-segmented into drug formulation, injection site modification, and device innovation. The product type segment can be bifurcated into device and drug. The device analysis includes wearable SC injectors and wearable SC infusors), while the drug analysis is given as (antibiotics, antiemetics, blood factors, diuretics, Immune Factors, Hematopoietic, Immunoglobulin G, Prostacyclin, Vasodilators, Immunotherapeutics, Remodulin, and others. Furthermore, by the therapeutic sector, the market is divided into edema, cardiology, hematology, blood factors, pulmonary arterial hypertension, and oncology.

    Regional Analysis

    Based on geography, the global intravenous-to-subcutaneous drug repositioning market is divided into North America, Asia-Pacific, Europe, South America, and Middle East & Africa. North America is further divided between the U.S., Canada, and Mexico. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

    Competitive Players

    Some of the key players profiled in the intravenous-to-subcutaneous drug repositioning industry include Baxalta, United Therapeutics, SteadyMed Therapeutics, and CSL Behring among others.

    Intravenous-to-Subcutaneous Drug Repositioning Market Key Segments:

    By Technology

    • Drug Formulation
    • Injection Site Modification
    • Device Innovation

    By Product

    • Devices
      • Wearable SC Injectors
      • Wearable SC Infusors
    • Drugs
      • Blood Factors
      • Diuretics
      • Immunoglobulin G
      • Antibiotics
      • Immunotherapeutics
      • Antiemetics
      • Hematopoietics
      • Immune Factors
      • Prostacyclin
      • Remodulin
      • Vasodilators
      • Others

    By Therapeutic Sector

    • Cardiology
    • Edema
    • Pulmonary Arterial Hypertension
    • Hematology
    • Blood Factors
    • Oncology

    By Geography

    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • U.K
      • Germany
      • France
      • Italy
      • Rest of Europe
    • Asia Pacific
      • India
      • China
      • Japan
      • South Korea
      • Rest of Asia Pacific
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Middle East & Africa
      • GCC Countries
      • Egypt
      • South Africa
      • Rest of Middle East & Africa
    keyboard_arrow_up
  • Table of Content

    1. Market Introduction
      • Executive Summary
      • Market Definition
      • Market Scope
    2. Research Methodology
      • Primary Research
      • Research Methodology
      • Assumptions & Exclusions
      • Secondary data sources
    3. Intravenous-to-Subcutaneous Drug Repositioning Market Overview
      • Report Segmentation & Scope
      • Key Market Trend
      • Drivers
        • Advantages over traditional drug discovery approaches
        • Significantly reduces the cost and development time as compared to the traditional therapies
        • Modernized technique for fast release of the drug
      • Restraint
        • lack of awareness regarding this therapies across developing regions
      • Opportunity
        • Surge in developing research labs and infra for conducting clinical trials
      • Porter’s Five Forces Analysis
        • Porter’s Five Forces Analysis
      • Market Share Analysis
    4. Technology Overview
      • Introduction
        • Market Size & Forecast
      • Drug Formulation
        • Market Size & Forecast
      • Injection Site Modification
        • Market Size & Forecast
      • Device Innovation
        • Market Size & Forecast
    1. Product Type Overview
      • Introduction
        • Market Size & Forecast
      • Device
        • Market Size & Forecast
      • Drug
        • Market Size & Forecast
    1. Therapeutic Sector Overview
      • Introduction
        • Market Size & Forecast
      • Cardiology
        • Market Size & Forecast
      • Hematology
        • Market Size & Forecast
      • Oncology
        • Market Size & Forecast
      • Edema
        • Market Size & Forecast
      • Blood Factors
        • Market Size & Forecast
      • Pulmonary Arterial Hypertension
        • Market Size & Forecast
    1. Intravenous-to-Subcutaneous Drug Repositioning Market Regional Overview
      • Introduction
        • Market Size & Forecast
      • North America Intravenous-to-Subcutaneous Drug Repositioning Market
        • North America Market Size & Forecast, By Country
        • North America Market Size & Forecast, By Product
        • North America Market Size & Forecast, By Therapeutic Sector
        • North America Market Size & Forecast, By Technology
        • S.
          • Market Size and Forecast
        • Canada
          • Market Size and Forecast
        • Mexico
          • Market Size and Forecast
        • Europe Intravenous-to-Subcutaneous Drug Repositioning Market
          • Europe Market Size & Forecast, By Country
          • Europe Market Size & Forecast, By Product
          • Europe Market Size & Forecast, By Therapeutic Sector
          • Europe Market Size & Forecast, By Technology
          • Germany
            • Market Size and Forecast
          • France
            • Market Size and Forecast
          • UK
            • Market Size and Forecast
          • Italy
            • Market Size and Forecast
          • Spain
            • Market Size and Forecast
          • Rest of Europe
            • Market Size and Forecast
          • Asia-Pacific Intravenous-to-Subcutaneous Drug Repositioning Market
            • Asia-Pacific Market Size & Forecast, By Country
            • Asia-Pacific Market Size & Forecast, By Product
            • Asia-Pacific Market Size & Forecast, By Therapeutic Sector
            • Asia-Pacific Market Size & Forecast, By Technology
            • Japan
              • Market Size and Forecast
            • China
              • Market Size and Forecast
            • Australia
              • Market Size and Forecast
            • India
              • Market Size and Forecast
            • South Korea
              • Market Size and Forecast
            • Rest of Asia-Pacific
              • Market Size and Forecast
            • South America Intravenous-to-Subcutaneous Drug Repositioning Market
              • South America Market Size & Forecast, By Country
              • South America Market Size & Forecast, By Product
              • South America Market Size & Forecast, By Therapeutic Sector
              • South America Market Size & Forecast, By Technology
              • Brazil
                • Market Size and Forecast
              • Argentina
                • Market Size and Forecast
              • Rest of South America
                • Market Size and Forecast
              • Middle East & Africa Intravenous-to-Subcutaneous Drug Repositioning Market
                • Middle East & Africa Market Size & Forecast, By Country
                • Middle East & Africa Market Size & Forecast, By Product
                • Middle East & Africa Market Size & Forecast, By Therapeutic Sector
                • Middle East & Africa Market Size & Forecast, By Technology
                • GCC Countries
                  • Market Size and Forecast
                • Egypt
                  • Market Size and Forecast
                • South Africa
                  • Market Size and Forecast
                • Rest of Middle East & Africa
                  • Market Size and Forecast
    1. Company Profile
      • Baxalta
        • Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • Baxalta Product Category, Application, and Specification
        • Baxalta Financial Performance (2016-2018)
        • Main Business/Business Overview
      • SteadyMed Therapeutics
      • United Therapeutics
      • CSL Behring

     

    keyboard_arrow_up
  • Key Global Intravenous-to-Subcutaneous Drug Repositioning Industry Players

    • Baxalta
    • SteadyMed Therapeutics
    • United Therapeutics
    • CSL Behring
    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Report Provides

  • Full in-depth analysis of the parent Industry
  • Important changes in market and its dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional growth potential

CLIENTS